No products in the cart.
Roll over image to zoom in
CELLMUNE 500MG TABLET
₹385.00₹630.01 (-39%)
Cellmune 500 mg Tablet is an anti-inflammatory with an active ingredient known as Mycophenolate mofetil. It is part of the inosine-monophosphate dehydrogenase (IMPDH) inhibitor class. The medicine is prescribed to avoid organ rejection in people who have received the organs of a donor (such as heart, kidney transplantation, or liver). It is a part of a treatment combination that includes other immunosuppressive medications.
This medication is not recommended during pregnancy due to the possibility of miscarriage and congenital disabilities. It is not recommended for pregnant women unless there are no other alternatives, and the advantages outweigh the risks. Women who are born are advised to utilize an effective contraceptive tablet to stop pregnancies. Live vaccines shouldn’t be administered while a patient takes the Cellmune 500mg Tablet because of the decreased vaccine effectiveness and the possibility of contracting infection. People taking this drug are not allowed to donate blood during treatment and, at minimum, six weeks after having stopped treatment. This ensures that the drug is eliminated from the body before blood donation.
It is usually advised not to take this drug in case you have an allergy to the medication or other components. Inform your doctor about heart or liver problems before beginning treatment. Because this drug weakens the body’s immune system, it increases the risk of developing skin cancer. People should minimize their exposure to sun or UV (UV) radiation. Contact your doctor right away in the event of bruising on your skin or fever. Unprovoked tiredness, dizziness or discoloration of the skin, eyes, vision impairment, decreased urinary output, or seizures following this medication. Cellmune 500 mg Tablet is an anti-inflammatory medication. It could affect the baby’s developing immune system and should not be used during breastfeeding. In certain instances, alternatives to drugs that have an improved safety profile for breastfeeding can be thought of as.